Patient-reported outcomes of first-line selpercatinib versus chemotherapy with or without pembrolizumab in RET fusion-positive advanced non-small cell lung cancer: Interim analysis of LIBRETTO-431

K. Goto,S. Novello,P. Garrido Lopez, C. Dooms, J. A. Alatorre Alexander, N. Reinmuth, A. Gilligan, N. Payakachat, A. Lin, K. Cocks, G. Worthy, C. Zhou

ANNALS OF ONCOLOGY（2023）

引用 0|浏览0